Floatz logo

Meropenem

Peritonitis Bacterial

Hannover Medical SchoolSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Peritonitis Bacterial cohort.

Asset / SponsorPhaseRating
Norfloxacin
Sherief Abd-Elsalam
Phase 4BBB
CARVEDILOL
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 4BB
PROPRANOLOL
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 4BB
Rifaximin
Centre Hospitalier Universitaire de Besancon
Phase 3B
Vivomixx
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase 3B

View all 10 →

Same molecule, other indications

Meropenem is also rated in:

pneumoniaDormant
B
Indicative ·
62 / 100
View asset →
Pseudomonas infectionDormant
B
Indicative ·
62 / 100
View asset →
sclerosing cholangitisDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →